Bui, Nam Q. https://orcid.org/0000-0001-6896-4349
Przybyl, Joanna
Trabucco, Sally E.
Frampton, Garrett
Hastie, Trevor
van de Rijn, Matt
Ganjoo, Kristen N.
Article History
Received: 29 June 2019
Accepted: 28 August 2019
First Online: 11 September 2019
Ethics approval and consent to participate
: This study was approved by the Stanford Institutional Review Board (IRB) of Stanford, CA.
: This manuscript does not contain data from any individual person.
: SET is employed by and has patents with Foundation Medicine, Inc. and has equity in F. Hoffmann-La Roche Ltd. GF is employed by and has patents with Foundation Medicine, Inc. and has equity in F. Hoffmann-La Roche Ltd. KNG has consulting roles with Novartis, Daiichi Sankyo, Janssen, and Eli Lilly. NQB, JP, TH, MvdR declare no competing interests.